The US Food and Drug Administration (USFDA) conducted a current Good Manufacturing Practices (cGMP) inspection at the manufacturing facility from February 6 - 17, the Mumbai-based drug firm said in a regulatory filing. On conclusion of the inspection, the company has received 8 inspectional observations in Form 483.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/L7jXluS
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Cipla's Pithampur unit gets 8 observations from US FDA after inspection
https://ift.tt/9msUGdy
No comments:
Post a Comment